Fuente: FierceBiotech Vivek Ramaswamy has found time out of his campaign for governor of Ohio to launch a new biotech. The new firm, Ambros Therapeutics, launched Tuesday with a $125 million series A and plans to develop a non-opioid pain medicine approved in Italy.